Incident Diabetes in Adolescents Using Antidepressant: A Systematic Review and Meta-Analysis Publisher Pubmed



Movahed F¹ ; Heidari E² ; Sadeghi D³ ; Rezaei Nejad A¹ ; Abyaneh R² ; Zarei M³ ; Beigi F⁴ ; Abdollahi A² ; Shafiee A² Show Affiliations
Source: European Child and Adolescent Psychiatry Published:2025

Abstract

Background: The use of antidepressants has been on the rise among adolescents and young adults, populations also increasingly at risk for type 2 diabetes. However, the relationship between antidepressant uses and diabetes incidence in these age groups remains poorly understood. Methods: Adhering to PRISMA guidelines and the Cochrane Handbook, we conducted a comprehensive search in PubMed, Scopus, Embase, and Web of Science up to 21 February 2024, registering our protocol on PROSPERO (CRD42024516272). Results: Six studies, ranging from 16, 470 to 1, 582, 914 participants and spanning 2010 to 2023 across North America, Europe, and Asia, were included. The meta-analysis revealed a significant association between antidepressant use and diabetes onset, with 10 cases per 1, 000 observations (p < 0.01; I2 = 100%). Adolescents using high doses of antidepressants showed a 62% increased risk of developing diabetes compared to non-users or those on low doses (Risk ratio = 1.67; 95% CI 1.19–2.35; I2 = 87%; p < 0.01). The overall quality of the studies was high, with an average Newcastle–Ottawa Scale score of 7.66. Sensitivity analysis highlighted the robustness of these findings, except when removing specific studies, indicating potential sources of heterogeneity. Conclusion: Antidepressant use in adolescents is associated with a significantly increased risk of diabetes onset, particularly at higher doses. This finding underscores the necessity for vigilant monitoring of glucose levels in this population and warrants further investigation into the underlying mechanisms and long-term outcomes. © Springer-Verlag GmbH Germany, part of Springer Nature 2024.